Primary biliary cirrhosis: An orchestrated immune response against epithelial cells

Immunological Reviews

Volumn 174, Issue , 2000, Pages 210-225

  Gershwin, M Eric ^a   Ansari, Aftab A ^b   Mackay, Ian R ^c   Nakanuma, Yasuni ^d   Nishio, Akiyoshi ^e   Rowley, Merrill J ^c   Coppel, Ross L ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONASH UNIVERSITY   (Australia)

^d KANAZAWA UNIVERSITY   (Japan)

^e TENRI HOSPITAL   (Japan)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; EPITOPE; FAS ANTIGEN; GRANZYME B; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOCHONDRION ANTIBODY; MUCIN; PERFORIN; PROTEIN BCL 2; PYRUVATE DEHYDROGENASE COMPLEX;

ANTIBODY PRODUCTION; ANTIGEN FUNCTION; AUTOIMMUNE DISEASE; BILE DUCT INJURY; CELL DEATH; CYTOKINE RELEASE; CYTOTOXICITY; EPITHELIUM CELL; GENDER; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOSUPPRESSIVE TREATMENT; LIVER INJURY; MOLECULAR MIMICRY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ACYLTRANSFERASES; AGE DISTRIBUTION; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BACTERIAL PROTEINS; BILE DUCTS; CELL LINE; CROSS REACTIONS; CYTOKINES; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; DOGS; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-D ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN A; LIVER CIRRHOSIS, BILIARY; MALE; MATERNAL-FETAL EXCHANGE; MIDDLE AGED; MITOCHONDRIA, LIVER; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDES; PREGNANCY; PROTEIN STRUCTURE, TERTIARY; PYRUVATE DEHYDROGENASE COMPLEX; SCLERODERMA, SYSTEMIC; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SEX DISTRIBUTION;

EID: 0034031785     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017402.x     Document Type: Review

References (126)

1. 1. Gershwin ME, Migliaccio CT, Van de Water J, Coppel RL. Molecular considerations of primary biliary cirrhosis. In: Lindor KD, Heathcote EJ, Poupon R, eds. Molecular considerations of primary biliary cirrhosis. Hingham: Kluwer Academic Publishers; 1998. p. 40-52.
2. 2. Gershwin ME. Molecular analysis of cytoplasmic autoantigens in liver disease. In: Rose NR, Mackay IR, eds. Molecular analysis of cytoplasmic autoantigens in liver disease. San Diego: Academic Press; 1992. p. 213-233.
3. 3. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl Med 1973;289:674-678.
4. 4. Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20:707-713.
5. 5. Floreani A, Naccarato R, Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy. J Hepatol 1997;26:737-740.
6. 6. Kato Y, et al. Familial primary biliary cirrhosis. Immunological and genetic study. Am J Gastroenterol 1981;75:188-191.
7. 7. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994;20:698-701.
8. 8. Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365-370.
9. 9. Parikh-Patel A, Gold E, Mackay I, Gershwin M. The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases. Clin Immunol 1999;91:206-218.
10. 10. Scheuer PJ. Liver biopsy interpretation. 3rd ed. London: Bailliere Tindall; 1980.
11. 11. Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979;76:1326-1332.
12. 12. Nakanuma Y, Tsuneyama K, Gershwin ME, Yashoshima M. Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Semin Liver Dis 1995;15:313-328.
13. 13. Coppel RL, et al. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 1988;85:7317-7321.
14. 14. Fregeau DR, Roche TE, Davis PA, Coppel R, Gershwin ME. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 α, a non-lipoic acid containing mitochondrial enzyme. J Immunol 1990;144:1671-1676.
15. 15. Fussey SP, Guest JR, James OF, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988;85:8654-8658.
16. 16. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525-3531.
17. 17. Surh CD, et al. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology 1989;10:127-133.
18. 18. Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988;167:1791-1799.
19. 19. Bassendine MF, Fussey SP, Mutimer DJ, James OF, Yeaman SJ. Identification and characterization of four M2 mitochondrial autoantigens in primary biliary cirrhosis. Semin Liver Dis 1989;9:124-131.
20. 20. Harris R, Bowker-Kinley M, Wu P, Jeng J, Popov K. Dihydrolipoamide dehydrogenase complex: DNA-derived amino acid sequence, expression, and reconstitution of the pyruvate dehydrogenase complex. J Biol Chem 1997;272:6361-6369.
21. 21. Yeaman SJ. The mammalian 2-oxoacid dehydrogenases: a complex family. Trends Biochem Sci 1986;11:293-297.
22. 22. Surh CD, Coppel R, Gershwin ME. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J Immunol 1990;144:3367-3374.
23. 23. Cha S, Leung PS, Coppel RL, Van de Water J, Ansari AA, Gershwin ME. Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis. Hepatology 1994;20:574-583.
24. 24. Leung PSC, et al. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 1995;22:505-513.
25. 25. Moteki S, et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996;24:97-103.
26. 26. Flannery GR, et al. Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens. Hepatology 1989;10:370-374.
27. 27. Fussey SP, Ali ST, Guest JR, James OF, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci USA 1990;87:3987-3991.
28. 28. Leung PS, Iwayama T, Coppel RL, Gershwin ME. Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2. Hepatology 1990;12:1321-1328.
29. 29. Quinn J, Diamond AG, Palmer JM, Bassendine MF, James OF, Yeaman SJ. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 1993;18:1384-1391.
30. 30. Fussey SP, Bassendine MF, Fittes D, Turner IB, James OF, Yeaman SJ. The E1 α and β subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis. Clin Sci 1989;77:365-368.
31. 31. Iwayama T, et al. Specific reactivity of recombinant human PDC-E1α in primary biliary cirrhosis. J Autoimmun 1991;4:769-778.
32. 32. Nishio A, et al. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 1997;25:1085-1089.
33. 33. Bandin O, Couvalin J, Poupon R, Dubel L, Homberg J, Johannet C. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 1996;23:1020-1024.
34. 34. Itoh S, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998;13:257-265.
35. 35. Wesierska-Gadek J, Honenauer H, Hitchman E, Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 1996;110:840-847.
36. 36. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994;106:193-199.
37. 37. Meuer SC, T, et al. Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol 1988;18:1447-1452.
38. 38. Moebius U, Manns M, Hess G, Kober G, Meyer zum Buschenfelde KH, Meuer SC. T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol 1990;20:889-896.
39. 39. Van de Water J, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991;146:89-94.
40. 40. Jones DEJ, Palmer JM, James OFW, Yeaman SJ, Bassendine MF, Diamond AG. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 1995;21:995-1002.
41. 41. Shimoda S, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998;102:1831-1840.
42. 42. Van de Water J, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995;181:723-733.
43. 43. Teoh KL, Mackay IR, Rowley MJ, Fussey SP. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 1994;19:1029-1033.
44. 44. Galbraith RM, Smith M, Mackenzie RM, Tee DE. Doniach D, Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med 1974;290:63-69.
45. 45. Salaspuro MP, Laitinen OI, Lehtola J, Makkonen H, Rasanen JA, Sipponen P. Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 1976;11:313-320.
46. 46. Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994;43:71-77.
47. 47. Begovich AB, Bugawan TL, Nepon BS, Klitz W, Nepon GT, Erlich HA. A specific Dp-b allele is associated with pauciarticular juvenile rheumatoid arthritis but not with adult rheumatoid arthritis. Proc Natl Acad Sci USA 1989;86:9489-9493.
48. 48. Dong RP, et al. HLA-DPB1 confers susceptibility to Grave's disease. Hum Pathol 1992;35:165-172.
49. 49. Arriaga F, et al. Association of HLA-DR3 antigen to disease with immunological components. Sangre (Barc) 1980;25:430-437.
50. 50. Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology 1987;7:889-892.
51. 51. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990;322:1842-1844.
52. 52. Manns MP, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991;101:1367-1373.
53. 53. Johnston DE, Kaplan MM, Miller KB, Connors CM, Milford EL. Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol 1987;82:1127-1129.
54. 54. Donaldson P, Doherty D, Underhill J, Williams R. The molecular genetics of autoimmune liver disease. Hepatology 1994;20:225-239.
55. 55. Bassendine MF, Dewar PJ, James OF. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 1985;26:625-628.
56. 56. Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 1987;29:141-145.
57. 57. Morling N, et al. DNA polymorphism of HLA class II genes in primary biliary cirrhosis. Immunogenetics 1992;35:112-116.
58. 58. Mella JG, Roschmann E, Maier KP, Volk BA. Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population. Hepatology 1995;21:398-402.
59. 59. Underhill JA, Donaldson PT, Doherty DG, Manabe K, Williams R. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 1995;21:959-962.
60. 60. Seki T, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology 1993;18:73-78.
61. 61. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995;181:1835-1845.
62. 62. Hillaire S, et al. Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes. Gastroenterology 1994;107:781-788.
63. 63. Adams DH, et al. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991;14:426-431.
64. 64. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984;2:1009-1013.
65. 65. Van den Oord J, Sciot R, Desmet V. Expression of MHC products by normal and abnormal bile duct epithelium in primary biliary cirrhosis. J Hepatol 1986;3:310-317.
66. 66. Tsuneyama K, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995;21:1031-1037.
67. 67. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 1993;34:1245-1249.
68. 68. Liu Y, Wenger R, Zhao M, Nielsen P. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med 1997;185:251-262.
69. 69. Schwartz R. Costimulation of T-lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068.
70. 70. Leon M, Kirby J, Gibbs P, Burt A, Bassendine M. Immunogenicity of biliary epithelial cells-study of the expression of B7 molecules. J Hepatol 1995;22:591-595.
71. 71. Leon M, Bassendine M, Gibbs P, Thick M, Kirby J. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 1997;112:968-977.
72. 72. Joplin R, Bakes S, Wallace L. Cytotoxicity of lymphocytes for autologous intrahepatic biliary epithelial cells in primary biliary cirrhosis. J Hepatol 1996;25:69.
73. 73. Krams SM, et al. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 1990;12:306-313.
74. 74. Hashimoto E, et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993;68:1049-1055.
75. 75. Colucci G, Schaffner F, Paronetto F. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin Immunol Immunopathol 1986;41:35-42.
76. 76. Terasaki S, Nakanuma Y, Yamazaki M, Unoura M. Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology 1993;17:206-212.
77. 77. Demetris AJ, Sever C, Kakizoe S, Oguma S, Starzl TE, Jaffe R. S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis? Am J Pathol 1989;134:741-747.
78. 78. Rontogianni D, Gerber H, Zimmermann A. Primary biliary cirrhosis (PBC): antigen-presenting cells differ in their distribution in early and late stage PBC and involve the ductal, but not the ductular compartment. Histol Histopathol 1994;9:211-220.
79. 79. Martinez O, Villanueva J, Gershwin ME, Krams S. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995;21:113-119.
80. 80. Charlton B, Lafferty K. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 1995;7:793-798.
81. 81. Harada K, et al. In situ hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997;25:791-796.
82. 82. Katayanagi K, et al. Generation of monoclonal antibodies to murine bile duct epithelial cells: identification of annexin V as a new marker of small intrahepatic bile ducts. Hepatology 1999;29:1019-1025.
83. 83. Joplin R, et al. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology 1991;14:442-447.
84. 84. Joplin RE, et al. Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis. Hepatology 1994;19:1375-1380.
85. 85. Van de Water J, et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 1996;24:1079-1084.
86. 86. Danpure CJ. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type I. J Nephrol 1998;11:8-12.
87. 87. Van de Water J, et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 1993;91:2653-2664.
88. 88. Joplin R, Wallace L, Lindsay J, Palmer J, Yeaman S, Neuberger J. The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X. Gastroenterology 1996;113:1727-1733.
89. 89. Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Enhanced apoptosis related to bile duct loss in primary biliary cirrhosis. Hepatology 1997;26:1399-1405.
90. 90. Koga H, Sakisaka S, Ohishi M, Sata M, Natikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997;25:1077-1084.
91. 91. Kuroki T, Seki S, Kawakita N, Nakitani K, Hisa T, Kitada T. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 1996;429:119-129.
92. 92. Yashoshima M, Kono N, Sugahara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-α in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 1998;78:89-100.
93. 93. Jelnick D, Lipsky P. Enhancement of human B-cell proliferation and differentiation by tumor necrosis factor α and interleukin 1. J Immunol 1987;139:2970-2976.
94. 94. Matsumoto K, Fujii H, Michalopoulos G, Fung J, Demetris J. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 1994;20:376-382.
95. 95. Gonzalez-Amaro R, et al. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841-848.
96. 96. Mano Y, Ishii M, Okamoto H, Igarashi T, Kobayashi K, Toyota T. Effect of tumor necrosis factor alpha on intrahepatic bile duct epithelial cells of rat liver. Hepatology 1996;23:1602-1607.
97. 97. Kieber M, Becker K, Pfanner N, Neupert W. Mitochondrial protein import: specific recognition membrane translocation of preproteins. J Membr Biol 1993;135:191-207.
98. 98. Migliaccio C, et al. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol 1998;161:5157-5163.
99. 99. Malmborg AC, et al. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun 1998;11:573-580.
100. 100. Tsianos EV, et al. Sjogren's syndrome in patients with primary biliary cirrhosis. Hepatology 1990;11:730-734.
101. 101. Epstein O, Thomas HC, Sherlock S. Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet 1980;1:1166-1168.
102. 102. Tsuneyama K, et al. Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjögren's syndrome. Hepatology 1994;20:893-898.
103. 103. Tsuneyama K, et al. Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry. Autoimmunity 1997;26:23-31.
104. 104. Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfitt W, Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut 1984;25:133-137.
105. 105. Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol 1993;17:408-414.
106. 106. Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta 1995;1271:111-121.
107. 107. Vilagut L, et al. Mycobacterium gordonae in primary biliary cirrhosis: possible etiology for the disease. J Hepatol 1993;18:S7.
108. 108. Vilagut L, Pares A, Vinas O, Vila J, Jimenez de Anta T, Rodes J. Antibodies to mycobacterial 65-kD heat shock protein cross-reacts with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur J Clin Invest 1997;27:667-672.
109. 109. O'Donohue J, McFarlane B, Bomford A, Yates M, Williams R. Antibodies to atypical mycobacteria in primary biliary cirrhosis. J Hepatol 1994;21:887-889.
110. 110. Klein R, Wiebel M, Engelhart S, Berg PA. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol 1993;92:308-316.
111. 111. Yeaman SJ, Fussey SP, Danner DJ, James OF, Mutimer DJ, Bassendine MF. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988;1:1067-1070.
112. 112. Owen P, Kaback HR, Grame-Cook KA. Identification of antigen 19/27 as dihydrolipoyl dehydrogenase and its probable involvement in ubiquinone-mediated NADH-dependent transport phenomena in membrane vesicles of Escherichia coli. FEMS Microbiol Lett 1980;7:345-348.
113. 113. De la Sierra IL, et al. Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis. J Mol Biol 1997;269:129-141.
114. 114. Danson MJ, Conroy K, McQuattie A, Stevenson K. Dihydrolipoamide dehydrogenase from Trypanosoma brucei: characterization and cellular location. Biochem J 1987;243:661-665.
115. 115. O'Donohue J, Fidler H, Garcia-Barcelo M, Nouri-Aria K, Williams R, McFadden J. Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis. J Hepatol 1998;28:433-438.
116. 116. Tanaka A, et al. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol (In press).
117. 117. Mason AL, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998;351:1620-1624.
118. 118. Fox RI. Sjögren's syndrome. Curr Opin Rheumatol 1995;7:409-416.
119. 119. Koike K, et al. Sialadenitis histologically resembling Sjögren's syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997;94:233-236.
120. 120. Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 1997;17:13-22.
121. 121. Neuberger J. Primary biliary cirrhosis. Lancet 1997;350:875-879.
122. 122. Czaja AJ. Chronic graft-versus-host disease and primary biliary cirrhosis: sorting the puzzle pieces. Lab Invest 1994;70:589-592.
123. 123. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996;93:705-708.
124. 124. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999;93:2033-2037.
125. 125. Nelson JL, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998:351-353.
126. 126. Arlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186-1191.